Literature DB >> 17644362

Association between prostaglandin E2 receptor gene and essential hypertension.

Mikano Sato1, Tomohiro Nakayama, Masayoshi Soma, Noriko Aoi, Kotoko Kosuge, Akira Haketa, Yoichi Izumi, Koichi Matsumoto, Naoyuki Sato, Shinichiro Kokubun.   

Abstract

BACKGROUND: Essential hypertension (EH) is a complex multifactorial polygenic disorder that is thought to result from an interaction between an individual's genetic makeup and various environmental factors. In the kidney, prostaglandins (PGs) are important mediators of vascular tone and salt and water homeostasis, and are involved in the mediation and/or modulation of hormonal action. In previous studies, mice deficient in the prostaglandin E2 (PGE(2)) EP2 receptor had resting systolic blood pressure (BP) that was significantly lower than that of wild-type controls. The BP of those mice increased when they were put on a high-salt diet, suggesting that the EP2 receptor is involved in sodium handling by the kidney. In the present study, we investigated the association between EH and nucleotide polymorphisms in the gene encoding the prostaglandin E2 receptor subtype EP2 (PTGER2).
METHODS: We selected three single-nucleotide polymorphisms (SNP) in the human PTGER2 gene (rs1254601, rs2075797, and rs17197), and we performed a genetic association study of 266 EH patients and 253 age-matched normotensive (NT) controls.
RESULTS: There was no significant difference in overall distribution of genotypes or alleles of any of the SNP between the EH and NT groups. However, among men, the A/A type of the SNP rs17197 (rs17197, A/G in 3'UTR) was significantly more frequent in EH subjects than in NT subjects (P=0.041).
CONCLUSION: The present findings suggest that rs17197 is useful as a genetic marker of EH in men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644362     DOI: 10.1016/j.plefa.2007.04.004

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  5 in total

1.  Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.

Authors:  Elizabeth M Poole; Li Hsu; Liren Xiao; Richard J Kulmacz; Christopher S Carlson; Peter S Rabinovitch; Karen W Makar; John D Potter; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

2.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

3.  TRPV1 and BDKRB2 receptor polymorphisms can influence the exercise pressor reflex.

Authors:  Karambir Notay; Shannon L Klingel; Jordan B Lee; Connor J Doherty; Jeremy D Seed; Michal Swiatczak; David M Mutch; Philip J Millar
Journal:  J Physiol       Date:  2018-09-19       Impact factor: 5.182

Review 4.  Pharmacogenomics of Prostaglandin and Leukotriene Receptors.

Authors:  José A Cornejo-García; James R Perkins; Raquel Jurado-Escobar; Elena García-Martín; José A Agúndez; Enrique Viguera; Natalia Pérez-Sánchez; Natalia Blanca-López
Journal:  Front Pharmacol       Date:  2016-09-21       Impact factor: 5.810

5.  The acute diuretic effect of an ethanolic fraction of Phyllanthus amarus (Euphorbiaceae) in rats involves prostaglandins.

Authors:  Alain N'guessan Yao; Mamadou Kamagaté; Augustin Kouao Amonkan; Philippe Chabert; Fidèle Kpahé; Camille Koffi; Mathieu N'goran Kouamé; Cyril Auger; Séraphin Kati-Coulibaly; Valérie Schini-Kerth; Henri Die-Kakou
Journal:  BMC Complement Altern Med       Date:  2018-03-15       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.